CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Planned sale Director sold 25,000 shares at $10.00 ($250,000)
- 4 Shares withheld for taxes Chief Financial Officer gave up 20,682 shares (to pay taxes)
- 4 Shares withheld for taxes See remarks gave up 58,170 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,673 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President gave up 77,560 shares (to pay taxes)
- 4 Planned sale Director sold 175,000 shares at an average $10.19 ($1,783,602)
- 10-K Report Annual Report
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Shares withheld for taxes See remarks gave up 118,560 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 42,643 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 2,257 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President gave up 140,048 shares (to pay taxes)
- 8-K Event Material agreement
- 4 Planned sale Director sold 151,967 shares at an average $7.20 ($1,094,297)
- 4 Planned sale Director sold 75,000 shares at an average $5.84 ($437,650)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 3 of 28 · 557 filings